Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Xuzhou Medical University

Clinical trials sponsored by Xuzhou Medical University, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Arthritis drug repurposed to fight stem cell transplant complication Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 2

Arthritis drug repurposed to fight stem cell transplant complication

Disease control Recruiting now

This phase 3 trial tests whether iguratimod, a drug already used for rheumatoid arthritis, can safely and effectively treat chronic graft-versus-host disease (cGVHD) in people who have had a stem cell transplant. The study will enroll 20 adults who have persistent cGVHD despite p…

Phase 3 • Sponsor: Xuzhou Medical University • Aim: Disease control

Last updated Jun 27, 2026 12:38 UTC